The master bacterial DNA replication initiator, DnaA, is a highly conserved multifunctional protein that utilises distinct domains to achieve its two key DNA binding activities. DnaA recognises double-stranded DNA using a helix-turn-helix motif (domain IV), whereas an ATP-dependent DnaA filament interacts with a single DNA strand using residues within the initiator specific motif (ISM; an α-helical insertion that distinguishes the family of replication initiators) of the AAA+ domain (domain III) ([Extended Data Fig. 1a-d](#F5){ref-type="fig"})[@R4],[@R5]. In contrast to DnaA, bacterial replication origins are diverse; they contain variable numbers of DnaA-boxes and seemingly lack a common architecture[@R6],[@R7]. Therefore, the sequence information within *oriC* that directs DnaA filament assembly onto a single DNA strand is unknown.

To investigate how DnaA filament formation could be localised to the DNA replication origin of *Bacillus subtilis* we began by characterising site-directed mutants of the DNA unwinding region *in vivo* ([Fig. 1a](#F1){ref-type="fig"} and [Extended Data Fig. 1e](#F5){ref-type="fig"}). In order to enable identification of essential sequences without selecting for suppressor mutations, we generated a strain in which DNA replication could initiate from a plasmid origin (*oriN*) integrated into the chromosome ([Fig. 1b](#F1){ref-type="fig"} and [Supplemental Information](#SD2){ref-type="supplementary-material"}). Activity of *oriN* requires its cognate initiator protein, RepN; both of these factors act independently of *oriC*/DnaA[@R8]. Expression of *repN* was placed under the control of a tightly-regulated inducible promoter, thus permitting both the introduction of mutations into *oriC* and their subsequent analysis following removal of the inducer to shut off *oriN* activity ([Fig. 1c](#F1){ref-type="fig"} and [Extended Data Fig. 2](#F6){ref-type="fig"}).

At the *B. subtilis* replication origin DNA unwinding by DnaA is detected downstream of DnaA-box elements and includes a sequence of 27 continuous A:T base pairs that is thought to facilitate DNA duplex opening ([Fig. 1a](#F1){ref-type="fig"})[@R9]. Surprisingly, we were able to delete the entire AT-rich 27-mer (Δ27) without abolishing origin activity, although the mutant strain did display a slow growth phenotype indicating that the AT-cluster is required for efficient origin function ([Fig. 1d](#F1){ref-type="fig"}). Interestingly, further deletions extending 3 or 6 base pairs (Δ30, Δ33) severely impaired *oriC*-dependent initiation ([Fig. 1d](#F1){ref-type="fig"}) and a deletion series targeting the sequence between the GC-rich and AT-rich clusters confirmed that this region alone was essential for origin function ([Fig. 1e](#F1){ref-type="fig"}). Scrambling this entire region also inhibited cell growth (t1--t6^Scr^), demonstrating that the specific sequence is required, rather than the spacing between the flanking elements ([Fig. 1f](#F1){ref-type="fig"}). To explore this region in more detail sequences were scrambled three base pairs at a time by exchanging each triplet for its complement. Phenotypic and marker frequency analyses revealed that disruption of sequences closest to the GC-cluster (t1^Scr^ and t2^Scr^) caused the greatest defect in DNA replication initiation, indicating that the region proximal to the DnaA-boxes is most important for origin activity ([Fig. 1f](#F1){ref-type="fig"}). Although mutagenesis of neither t4 nor t5 alone produced a detectable effect on DNA replication initiation under the conditions tested, they may become important when origin firing is suboptimal as was observed in the AT-cluster deletion mutant ([Fig. 1d](#F1){ref-type="fig"}).

To determine whether this essential DNA sequence between the GC- and AT-clusters has a role in DNA melting *per se*, an open complex formation assay was performed. DnaA was incubated with *oriC* plasmids containing either the wild-type or scrambled sequence (t1-t6^Scr^), potassium permanganate was added to oxidise distorted bases within the DNA, and base modification was detected by primer extension. Scrambling the sequence inhibited open complex formation, indicating that this region is necessary for DnaA-dependent unwinding ([Fig. 1g](#F1){ref-type="fig"}).

DnaA monomers are thought to bind DnaA-boxes prior to ATP-dependent filament formation[@R10]. Using the strain capable of *oriC*-independent initiation the seven DnaA-box sequences were individually scrambled to abolish DnaA binding[@R11]. Culturing these strains in the absence of *oriN* activity revealed that mutation of DnaA-box6 severely inhibited growth and mutation of DnaA-box7 resulted in a significant growth defect, while mutation of the remaining DnaA-boxes had no observable effect ([Fig. 2a](#F2){ref-type="fig"}). Marker frequency analysis confirmed that mutation of DnaA-box7 drastically impaired origin activity, whereas mutation of the remaining DnaA-boxes resulted in only modest decreases in initiation frequency ([Fig. 2a](#F2){ref-type="fig"}). These results indicate that DnaA-boxes proximal to the essential unwinding region are most critical for origin activity.

To directly test whether these DnaA-boxes promote DnaA filament assembly at the essential unwinding region we utilised a previously described DnaA filament formation assay[@R12]. Here two cysteine residues are introduced within the AAA+ domain such that the protein remains functional and when the DnaA filament assembles the cysteine residues from interacting protomers come into close proximity. DNA scaffolds were assembled using oligonucleotides and the cysteine-specific crosslinker bis(maleimido)ethane (BMOE; 8 Å spacer arm) was used to capture the oligomeric species formed on each substrate.

Incubation of DnaA with duplex substrates containing DnaA-box6, DnaA-box7 and the GC-rich region produced a dimeric species ([Fig 2b-c](#F2){ref-type="fig"}), whereas incubation of DnaA with a longer duplex substrate containing the unwinding region produced a set of larger oligomeric complexes. We wondered whether the larger species were being formed on the duplex DNA or on a single DNA strand. To test these models scaffolds containing single-stranded (ss) DNA tails were assembled. DnaA filaments readily formed on substrates containing a 5′-tail but were absent when the corresponding 3′-tail was provided ([Fig. 2c](#F2){ref-type="fig"} and [Extended Data Fig. 3](#F7){ref-type="fig"}). Formation of DnaA oligomers on the 5′-tailed substrate was dependent upon both ATP and the ssDNA binding residue Ile190 located within the ISM of the AAA+ domain[@R4], indicating that the assay was capturing DnaA filament formation on ssDNA ([Fig. 2c--d](#F2){ref-type="fig"}, [Extended Data Fig. 1d](#F5){ref-type="fig"}).

Critically, DnaA oligomer formation on the 5′-tailed substrate was specific. DnaA filament assembly was abolished when the DnaA-box sequences within the duplex region were scrambled and it was significantly reduced when the single-stranded region was replaced with its complementary sequence ([Fig. 2c](#F2){ref-type="fig"}). Taken together these results suggest that DnaA filaments are loaded from duplex DnaA-boxes onto ssDNA bearing a 5′-tail. This model is consistent with both biochemical experiments showing that *E. coli* DnaA preferentially interacts with the corresponding single-strand of its DUE and single molecule studies showing that *Aquifex aeolicus* DnaA filaments form with 3′→5′ polarity[@R11],[@R13],[@R14].

DnaA oligomer size was proportional to the length of the 5′-tail up to the formation of a heptamer, after which further DNA extension did not promote longer filaments ([Fig. 2e-f](#F2){ref-type="fig"}). We noted that this limit corresponded to a poly(A) tract in the DNA sequence and wondered whether this sequence inhibited DnaA filament formation. When the poly(A) tract was replaced by sequences from the beginning of the DNA unwinding region, DnaA oligomer length increased beyond a heptamer ([Fig. 2e-f](#F2){ref-type="fig"}). This result suggests that the origin unwinding region is designed to limit DnaA filament formation to a precise position within *oriC*.

To identify a possible single-strand binding motif recognised by DnaA, individual base pairs within the essential unwinding region were inverted and origin activity was analysed *in vivo*. Marker frequency analysis revealed that altering either of two A:T base pairs, which were spaced three nucleotides apart from each other, resulted in the most significant loss of origin activity; in contrast the surrounding mutations had only modest effects ([Fig. 3a](#F3){ref-type="fig"}). Re-examination of the unwinding region shows that A:T base pairs are spaced at three nucleotide intervals throughout this sequence ([Fig. 1a](#F1){ref-type="fig"}). This observation is strikingly congruent with the mechanism proposed for binding of the DnaA filament to ssDNA, where each protomer engages a set of three nucleotides ([Fig. 3b](#F3){ref-type="fig"})[@R4].

We hypothesised that an array of triplet nucleotide motifs recognised by DnaA are present within the unwinding region and that the motifs proximal to the DnaA-boxes are most important for origin activity. To test this model *in vivo* we created a set of nested deletions that removed either one or three base pairs ([Extended Data Fig. 4](#F8){ref-type="fig"}). All of the single base pair deletions dramatically lowered the replication initiation frequency and several significantly inhibited cell growth (especially the same A:T base pairs noted above), whereas triplet deletions encompassing the single deletions had little or no effect ([Fig. 3c-d](#F3){ref-type="fig"}). These results are consistent with the model that single base pair deletions act both by disrupting a specific 3-mer motif and by shifting the register of downstream 3-mer motifs relative to the DnaA filament start point at the DnaA-boxes.

To test the model that the ssDnaA binding motif is indeed a repeating 3-mer, DnaA filament formation was analysed *in vitro* using tailed substrates which contained either single or triplet base deletions ([Fig. 3e](#F3){ref-type="fig"}). Whereas deletion of one base produced significantly shorter oligomers, deletion of three bases restored formation of full length complexes. Taken together with the *in vivo* deletions, these results indicate that DnaA filaments bind to ssDNA by recognising a specific 3-mer motif found within the unwinding region. We have termed this 3-mer motif the "DnaA-trio".

To define the precise sequence of the DnaA-trio, DnaA filament formation was observed using a series of DNA scaffolds in which the 5′-tails were extended by increments of one nucleotide. We observed that additional oligomeric species appeared after the following sequences were added: 3′-GAT-5′, 3′-AAT-5′ and 3′-GAA-5′, suggesting that these triplets represent individual DnaA-trio motifs ([Fig. 4a](#F4){ref-type="fig"}).

However, it was surprising that a longer oligomer was not formed following addition of the first 3′-GAT-5′ motif proximal to the GC-cluster, since mutagenesis of this sequence *in vivo* resulted in strong phenotypes ([Fig. 3a, 3c-d](#F3){ref-type="fig"}). In structures of the archaeal initiator Orc1 bound to a replication origin the protein was observed to make two contacts with the DNA, one through its C-terminal DNA binding domain (analogous to DnaA domain IV) and another through its AAA+ motif[@R15],[@R16]. We wondered whether DnaA might similarly be capable of contacting both a DnaA-box and the first DnaA-trio, thereby accounting for the absence of a DnaA trimer. Significantly, BMOE crosslinking of cysteines in the AAA+ domain would not detect this activity as the assay captures DnaA oligomers formed on either double-stranded or ssDNA[@R12].

In order to test this hypothesis we employed the amine-specific crosslinker bis(sulfosuccinimidyl)suberate (BS^3^) which, in contrast to BMOE, only captures DnaA oligomers formed on a single DNA strand ([Extended Data Fig. 3](#F7){ref-type="fig"} and [5](#F9){ref-type="fig"}). Crosslinking by BS^3^ reveals a DnaA dimer forming in the presence of the first 3′-GAT-5′, indicating that DnaA does recognise this sequence ([Extended Data Fig. 5](#F9){ref-type="fig"}). Taken together with the BMOE crosslinking showing that a DnaA dimer is formed on the double-stranded DNA scaffold containing just DnaA-boxes 6 and 7 and the GC-cluster, the data suggests that the DnaA protein initially bound at DnaA-box7 undergoes a conformational change (detected by BS^3^) to engage the first DnaA-trio motif following the GC-cluster. Several lines of evidence support the notion that DnaA adopts distinct conformations when it engages either double-stranded or ssDNA[@R17],[@R18].

To support the assignment of the DnaA-trio we performed a targeted mutagenesis of the proposed sequence. The results indicate that each of the positions (3′-GAT-5′) appears important for DnaA filament formation, specifically the nucleotides at positions 1 and 2, and the deoxyribose group at position 3 ([Fig. 4b](#F4){ref-type="fig"} and [Extended Data Fig. 6](#F10){ref-type="fig"}). Interestingly, in the crystal structure of DnaA bound to a ssDNA substrate the protein makes no base-specific contacts[@R4]. These observations suggest either that the sequence of the DnaA-trios is important for an intermediate step in DNA duplex recognition and melting prior to full engagement of the product single-strand, or that the specific base sequence promotes the DNA backbone to adopt a favourable geometry for DnaA binding.

Using this information we first searched for DnaA-trios within other well-characterised origin unwinding elements ([Fig. 4c](#F4){ref-type="fig"}; underlined)[@R19]--[@R21]. In these cases a set of at least three DnaA-trios could be identified. These DnaA-trios were located proximal to a DnaA-box that shared the same orientation as *B. subtilis* DnaA-box7 and the regions between the DnaA-box and the DnaA-trios were GC-rich. Using these additional criteria we next interrogated predicted bacterial DNA replication origins (DoriC[@R22]) for similar patterns. [Figure 4c](#F4){ref-type="fig"} shows that similar elements can be identified within putative *oriC* regions throughout the bacterial kingdom. A sequence logo of the DnaA-trios indicates that the preferred motif is 3′-^G^/~A~AT-5′ ([Fig. 4d](#F4){ref-type="fig"}), with the central adenine being most highly conserved. We also observed that in the majority of cases a pair of tandem DnaA-boxes preceded the GC-cluster ([Extended Data Table 1](#T1){ref-type="table"}).

We propose that the DnaA-trio constitutes a new element within bacterial replication origins. Our findings indicate that DnaA-trios play an essential role during DNA replication initiation by providing specificity for DnaA filament formation on a single DNA strand, thereby promoting DNA duplex unwinding. Our analysis also indicates that the arrangement of tandem DnaA-boxes in close proximity to DnaA-trios comprises a widespread strategy used to direct DnaA filament growth onto the unwinding region, with a single DnaA protein likely binding double-strand DNA via domain IV prior to engaging a DnaA-trio via its AAA+ motif ([Fig. 4e](#F4){ref-type="fig"} and [Extended Data Fig. 5](#F9){ref-type="fig"}). Together our data is consistent with the two-step DnaA assembly model for DNA melting[@R18].

We note that the configuration between DnaA-boxes and the DnaA-trios is not strictly required for DnaA to be loaded onto the single DNA strand *in vitro*. Scaffolds containing either a single DnaA-box or containing DnaA-boxes in reverse orientation are competent to promote DnaA filament formation from the duplex DNA onto the 5′-tail, although in the latter situation DnaA filament formation was reduced suggesting that DnaA-box orientation is important ([Extended Data Fig. 7](#F11){ref-type="fig"}). Furthermore, loading does not require the flexibly tethered domains I/II of DnaA, consistent with previous observations suggesting that domains III/IV can adopt multiple conformations ([Extended Data Fig. 7](#F11){ref-type="fig"})[@R12],[@R17],[@R18]. These results suggest that some plasticity can be accommodated between duplex and single-strand DNA binding elements, which is in agreement with recent reanalyses of essential DnaA-boxes in *E. coli* and may also explain the location of atypical origin unwinding sites[@R23]--[@R26].

Analysis of replication initiator proteins from both bacteria and archaea shows that the ISM within AAA+ domains is utilised for DNA binding and the recent structure of the *Drosophila* origin recognition complex (ORC) suggests that this is also likely the case for eukaryotes, supporting the model that DNA binding by the ISM is a universal feature of replication initiators[@R4],[@R15],[@R16],[@R27]. We find here, for the first time, that the interaction of the *B. subtilis* replication initiator ISM with the origin involves recognition of a specific DNA sequence. We speculate that motifs analogous to the DnaA-trio may be present in replication origins of higher organisms and be recognised by the ISM of ORC proteins. These sites need not be 3-mers, nor would they necessarily share the same spacing observed for the DnaA-trios as they would need to accommodate the arrangement of AAA+ interactions within the respective heterohexameric ORC[@R17],[@R27]. The discovery of ISM binding motifs in higher organisms would greatly facilitate origin identification, an elusive problem precluding the understanding of DNA replication control in eukaryotes.

Methods {#S1}
=======

Media and chemicals {#S2}
-------------------

Nutrient agar (NA; Oxoid) was used for routine selection and maintenance of both *B. subtilis* and *E. coli* strains. For experiments in *B. subtilis* cells were grown using Luria-Bertani (LB) medium. Supplements were added as required: chloramphenicol (5 µg/ml), erythromycin (1 µg/ml), kanamycin (5 µg/ml), spectinomycin (50 µg/ml). Unless otherwise stated all chemicals and reagents were obtained from Sigma-Aldrich.

Phenotype analysis of oriC mutants using the inducible oriC-independent strain {#S3}
------------------------------------------------------------------------------

Strains were grown for 18-72 hr at 37°C on NA plates either with or without IPTG (1 mM). All experiments were independently performed at least twice and representative data is shown.

Marker frequency analysis {#S4}
-------------------------

Genomic DNA was harvested from cells during the exponential growth phase and the relative amount of DNA from the replication origin (*ori*) and terminus (*ter*) was determined by qPCR. Strains were grown in LB medium to an A~600~ of 0.3-0.5 whereupon sodium azide (0.5%; Sigma) was added to prevent further metabolism. Chromosomal DNA was isolated using a DNeasy Blood and Tissue Kit (Qiagen). The DNA replication origin (*oriC*) region was amplified using primers 5′-GAATTCCTTCAGGCCATTGA-3′ and 5′-GATTTCTGGCGAATTGGAAG-3′; the region adjacent to *oriN* was amplified using primers 5′-CTTTCTGCCGCAAAGGATTA-3′ and 5′- CCTCTTCATAGCCGTTTTGC-3′; the DNA replication terminus (*ter*) region was amplified using primers 5′-TCCATATCCTCGCTCCTACG-3′ and 5′-ATTCTGCTGATGTGCAATGG-3′. Either Rotor-Gene SYBR Green (Qiagen) or GoTaq (Promega) qPCR mix was used for PCR reactions. qPCR was performed in a Rotor-Gene Q Instrument (Qiagen). By use of crossing points (C~T~) and PCR efficiency a relative quantification analysis (ΔΔC~T~) was performed using Rotor-Gene Software version 2.0.2 (Qiagen) to determine the origin:terminus (*ori:ter*) ratio of each sample. These results were normalised to the *ori:ter* ratio of a DNA sample from *B. subtilis* spores, which only contain one chromosome and thus have an *ori:ter* ratio of 1. Error bars indicate the standard deviation of three technical replicates. All experiments were independently performed at least twice and representative data is shown.

Protein expression {#S5}
------------------

BL21 (DE3)-pLysS cells were transformed with the appropriate expression construct ([Supplementary Table 2](#SD2){ref-type="supplementary-material"}) and selected on nutrient agar plates containing 100 ng/µl of ampicillin and 34 ng/µl of chloramphenicol. A single transformant colony was used to inoculate an overnight starter culture grown at 37 °C, 180 rpm, in LB medium supplemented with 100 ng/µl of ampicillin and 34 ng/µl of chloramphenicol. The following morning a 1/100 dilution of overnight culture was used to inoculate 1200 ml of LB medium supplemented with 100 ng/µl of ampicillin and grown at 37°C, 180 rpm, to an A~600~ of 0.5. Cells were induced with 1 mM IPTG and cultured for a further 3 hr at 30°C. Cells were pelleted at 3,000 g, 4°C for 10 min before resuspension in 45 ml pf resuspension buffer (25 mM HEPES-KOH (pH7.6); 500 mM potassium glutamate; 10 mM magnesium acetate; 20% sucrose; 30 mM imidazole; 1 x cOmplete EDTA-free protease inhibitor tablet (Roche). The cell suspension was then flash-frozen in liquid nitrogen.

Protein purification {#S6}
--------------------

DnaA (WT, WT-CC and I190A-CC) was purified as follows. A frozen 50 ml BL21 cell pellet suspension was thawed on ice with 32 mg of lysozyme and gentle agitation for 1 hr then disrupted by sonication at 20 W for 5 min in 2 s pulses. Cell debris was pelleted by centrifugation at 31,000 xg, 4°C for 45 min and the supernatant further clarified by filtration (0.45 µm). All subsequent steps were performed at 4 °C unless otherwise stated. The clarified lysate was applied at 1 ml/minute to a 1 ml HisTrap HP column (GE), which had previously been equilibrated with Ni binding buffer (25 mM HEPES-KOH \[pH7.6\]; 250 mM potassium glutamate; 10 mM magnesium acetate; 20% sucrose; 30 mM imidazole). The loaded column was washed with a 10 ml 1 step gradient of 10 % Ni elution buffer (25 mM HEPES-KOH \[pH7.6\]; 250 mM potassium glutamate; 10 mM magnesium acetate; 20% sucrose; 30 mM imidazole). Specifically-bound proteins were eluted using a 7.5 ml 1-step gradient of 100% Ni elution buffer and the entire fraction collected and diluted into 42.5 ml of Q binding buffer (30 mM Tris-HCl \[pH7.6\]; 100 mM potassium glutamate; 10 mM magnesium acetate; 1 mM DTT; 20% sucrose). The diluted fraction was then applied at 1 ml/min to a 1 ml HiTrap Q HP column (GE), which had previously been equilibrated with Q binding buffer. The loaded HiTrap Q HP column was washed with 10 ml of Q binding buffer then eluted using a linear 10 ml gradient of 0--100% Q elution buffer (30 mM Tris-HCl \[pH7.6\]; 1 M potassium glutamate; 10 mM magnesium acetate; 1 mM DTT; 20% sucrose) with 1 ml fractions collected. The peak 3 × 1 ml fractions, based on UV absorbance, were pooled and dialysed into 1 L of FactorXa cleavage buffer (25 mM HEPES-KOH \[pH7.6\]; 250 mM potassium glutamate; 20% sucrose; 5 mM CaCl~2~), using 3.5k MWCO SnakeSkin dialysis tubing (Life Technologies) at 4°C overnight. The dialysed protein was diluted to 5 ml total volume in FactorXa cleavage buffer and incubated at 23 °C for 6 hr with 80 µg of FactorXa protease (NEB). The sample was applied at 1 ml/min to a 1 ml HisTrap HP column (GE), which had previously been equilibrated with Factor Xa cleavage buffer. The Factor Xa-cleaved fraction was eluted in 7.5 ml of Ni binding buffer. The eluted fraction was diluted into 42.5 ml of Q binding buffer and purified on a 1 ml HiTrap Q HP column as previously described. Peak fraction(s) were pooled and dialysed into 1 L of final dialysis buffer (40 mM HEPES-KOH \[pH7.6\]; 250 mM potassium glutamate; 1 mM DTT; 20% sucrose; 20% PEG~300~), using 3.5k MWCO SnakeSkin dialysis tubing (Life Technologies) at 4°C overnight before aliquoting, flash-freezing in liquid nitrogen and storage at -80 °C. Removal of the N-terminal His-tag, following incubation with FactorXa, was confirmed by anti-pentaHis (Qiagen) Western blotting.

C-terminally His-tagged DnaA (WT-CC and Δ(domainI-II)-CC) purification was performed as for the tag-free variants, except that the protein was dialysed into final dialysis buffer following the first HiTrap Q HP column purification before aliquoting, flash-freezing and storing.

HBsU purification was performed exactly as for DnaA, except that the HiTrap Q HP column was substituted for a 1 ml HiTrap Heparin HP column (GE) and the composition of buffers was modified accordingly. Ni binding buffer (25 mM Tris-HCl \[pH8.0\]; 400 mM NaCl; 30 mM imidazole). Ni elution buffer (25 mM Tris-HCl \[pH8.0\]; 400 mM NaCl; 500 mM imidazole). Heparin binding buffer (25 mM Tris-HCl \[pH8.0\]; 100 mM NaCl; 1 mM EDTA). Heparin elution buffer (25 mM Tris-HCl \[pH8.0\]; 2 M NaCl; 1 mM EDTA). Factor Xa cleavage buffer (25 mM Tris-HCl \[pH8.0\]; 100 mM NaCl; 2 mM CaCl~2~; 20% sucrose). Final dialysis buffer (25 mM Tris-HCl \[pH8.0\]; 400 mM NaCl; 2 mM CaCl~2~; 20% sucrose; 20 % PEG~300~). Peak fractions were determined by SDS-PAGE and Coomassie staining due to the absence of tryptophan, tyrosine and cysteine residues.

Open complex formation assays {#S7}
-----------------------------

KMnO~4~ footprinting assays were essentially performed as described in [@R9], except for the following changes. DnaA was not pre-incubated with ATP. The unwinding buffer contained 2 mM ATP, rather than 5 mM, and 500 ng of plasmid pTR541 (wild-type) or pTR542 (t1-t6^scr^) was used per 75 µl-scale reaction. DnaA was added to final concentrations of 0, 100, 250, 500 and 1000 nM. Assembled reactions were incubated at 37 °C for 10 min. KMnO~4~ treatment was then performed at 37 °C for 10 min. Six µl of β-mercaptoethanol was used to quench reactions; however, EDTA was omitted. KMnO~4~-treated DNA was immediately purified using a Qiagen PCR clean-up kit, eluting in 20 µl of EB buffer. KMnO~4~-treated templates were not linearised prior to primer extension. Primer extensions were performed on a 20 µl scale using 0.1 U/µl of Vent exo- DNA polymerase (NEB) in 1x manufacturer's reaction buffer supplemented with 4 mM MgSO~4~, 200 µM each dNTP, 200 nM Cy5-labelled oligonucleotide (5'-Cy5- AGCTTCAGCAGCATGTAAAAG-3') and 4 µl of PCR-purified template DNA per reaction. Reactions were subjected to thermocycling using a [@R3]Prime thermal cycler (Techne) with 1 min initial denaturation at 98 °C, followed by 35 cycles of (10 s at 98 °C; 30 s at 55 °C; 30 s at 72 °C). Reactions were quenched by addition of an equal volume of stop buffer (95% formamide; 10 mM EDTA; 10 mM NaOH; 0.01% Orange-G) and products subjected to denaturing PAGE (6% acrylamide:bisacrylamide \[19:1\]; 8 M urea in 1x TBE). Resolved products were visualised using a Typhoon Trio Variable Mode Imager (GE Healthcare). The DnaA-trio marker was generated by primer extension performed under the same conditions as described for KMnO~4~-treated substrates, but using a PCR product as template generated with a primer corresponding to the end of the first DnaA-trio (5'- TAGGGCCTGTGGATTTGTG -3'). All experiments were independently performed at least twice and representative data is shown.

Filament assembly assays (BMOE) {#S8}
-------------------------------

DNA scaffolds were prepared by mixing each oligonucleotide (50 nM final concentrations) in 10 mM HEPES-KOH (pH7.6), 100 mM NaCl and 1 mM EDTA. Mixed oligonucleotides were heated to 98°C for 5 min in a heat-block and slowly cooled to room-temperature in the heat-block before use. Filament formation was promoted by mixing DnaA-CC proteins (WT, I190A, ΔdomainI-II) (200 nM final concentration) with DNA scaffold (15 nM) on a 20 µl-scale in 30 mM HEPES-KOH (pH7.0), 100 mM potassium glutamate, 100 mM NaCl, 10 mM magnesium acetate, 25% glycerol, 0.01% Tween-20 and 2 mM nucleotide (ADP or ATP). Reactions were incubated at 37°C for 5-12 min before addition of 4 mM BMOE (ThermoFisher Scientific). Reactions were incubated at 37°C for 5-12 min before quenching by addition of 60 mM cysteine. Reactions were incubated once more at 37°C for 10-12 min before fixing in NuPAGE LDS sample buffer (ThermoFisher Scientific) at 98°C for 5 min. Complexes were resolved by running 500 fmol of cross-linked DnaA from each reaction on a NuPAGE Novex 3-8% Tris-Acetate gel (ThermoFisher Scientific) then transferred to Hybond 0.45 µm PVDF membrane (Amersham) in 0.5x NuPAGE Tris-acetate SDS running buffer with 20% MeOH at 35 mA, 4°C overnight using wet transfer apparatus (Biorad). Complexes were visualised by Western blotting using a polyclonal anti-DnaA antibody (Eurogentec). NB/ All filament assembly assays were performed using tag-free proteins with the exception of that shown in Extended Data Figure 9, in which C-terminally His-tagged proteins (ΔdomainI-II-CC and wild-type-CC) were employed. All experiments were independently performed at least twice and representative data is shown.

Filament assembly assays (BS^3^) {#S9}
--------------------------------

Filament assembly assays using bis(sulfosuccinimidyl)suberate (BS^3^) were performed as described for BMOE, except a tag-free fully wild-type recombinant DnaA protein was employed for [Extended Data Figure 5](#F9){ref-type="fig"}. Tag-free "CC" variants of wild-type and I190A DnaA were used for [Extended Data Figure 7a,b](#F11){ref-type="fig"}. Crosslinking was performed using BS^3^ (15 mM final concentration) in place of BMOE and quenching performed by addition of Tris-HCl \[pH7.6\] (30 mM final concentration). All experiments were independently performed at least twice and representative data is shown.

Microscopy {#S10}
----------

To visualise GFP-DnaN, starter cultures were grown overnight in defined minimal medium base (Spizizen minimal salts supplemented with Fe-NH~4~-citrate (1 µg/ml), MgSO~4~ (6 mM), CaCl~2~ (100 µM), MnSO~4~ (130 µM), ZnCl~2~ (1 µM), thiamine (2 µM)) supplemented with casein hydrolysate (200 µg/ml) and glycerol (0.5%) with IPTG (1 mM) at 37°C, diluted 1:100 into fresh medium with IPTG (1 mM) and allowed to grow at 37°C for several generations until they reached an A~600~ 0.3. Cells were collected by centrifugation, washed to remove IPTG, and resuspended into fresh medium at an A~600~ 0.1 and allowed to grow until an A~600~ 0.6. Cells were mounted on 1.5% agar pads (0.5X growth media) and a 0.13--0.17 mm glass coverslip (VWR) was placed on top. Microscopy was performed on an inverted epifluorescence microscope (Nikon Ti) fitted with a Plan-Apochromat objective (Nikon DM 100x/1.40 Oil Ph3). Light was transmitted from a 300 Watt xenon arc-lamp through a liquid light guide (Sutter Instruments) and images were collected using a CoolSnap HQ^2^ cooled CCD camera (Photometrics). All filters were Modified Magnetron ET Sets from Chroma and details are available upon request. Digital images were acquired and analysed using METAMORPH software (version V.6.2r6). All experiments were independently performed at least twice and representative data is shown.

Strains {#S11}
-------

Strains are listed in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}. The genotype of all origin mutants was confirmed by DNA sequencing.

Oligonucleotides {#S12}
----------------

All oligonucleotides were purchased from Eurogentec. Oligonucleotides used for plasmid construction are listed in [Extended Data Table 2](#T2){ref-type="table"}. Oligonucleotides used to construct DNA scaffolds are listed in [Extended Data Table 3](#T3){ref-type="table"}.

Plasmids {#S13}
--------

Plasmids are listed in the [Supplementary Table 2](#SD2){ref-type="supplementary-material"} (sequences are available upon request). DH5α (F^-^ Φ80*lac*ZΔM15 Δ(*lac*ZYA-*arg*F) U169 *rec*A1 *end*A1 *hsd*R17(r~k~^-^, m~k~^+^) *pho*A *sup*E44 *thi*-1 *gyr*A96 *rel*A1 λ^-^)[@R29] was used for plasmid construction, except where noted. Descriptions, where necessary, are provided below.

[pHM327 derivatives]{.ul} were generated by quickchange mutagenesis using the oligonucleotides listed in [Extended Data Table 2](#T2){ref-type="table"}. Following sequencing to confirm mutated regions, sequences were subcloned using BglII/FspAI.

[pHM446]{.ul} \[*bla aprE′ kan lacI* P~spac~-MCS *′aprE*\] is a derivative of pAPNC213[@R30] with a kanamycin resistance cassette replacing the spectinomycin resistance cassette (gift from H. Strahl).

[pHM453]{.ul} \[*bla rpnA′ rpmH erm* Δ*incAB* P~spac~-*dnaA′*\] was created in multiple steps. First, pJS1 was generated by ligation with a *Hin*dIII-*Bam*HI PCR product containing 5′ end of *dnaA* and pMUTIN4[@R31] cut with *Hin*dIII-*Bam*HI (gift from J. Errington). Second, pHM396 was generated by digestion of pJS1 with *Pvu*II (to remove *lacZ and lacI*) and ligation of the vector backbone. Finally, pHM453 was generated by ligation of an *Aat*II PCR product containing *rpmH* and the 5′ end of *rpnA* (oHM319 + oHM320 and 168CA genomic DNA as template) with pHM396 cut with *Aat*II.

[pHM492]{.ul} \[*bla aprE′ kan lacI* P~spac~-*repN*(*oriN*) *′aprE*\] was generated by ligation of an *Eco*RI-*Xho*I PCR product containing *repN*(*oriN*) (oHM313 + oHM315 and MMB208[@R32] genomic DNA as template) with pHM446 cut with *Eco*RI-*Sal*I.

[pHM560]{.ul} \[*bla rpnA′ rpmH erm* Δ*incA* P~dnaA~ Δ*incB dnaA′*\] was generated by ligation of an *Eco*RV-*Hin*dIII PCR product containing the *dnaA* promoter (oHM510 + oHM511 and 168CA genomic DNA as template) with pHM453 cut with *Eco*RV-*Hin*dIII.

[pTR72, pTR73, pTR74, pTR102, pTR168]{.ul} were generated by quickchange mutagenesis using the oligonucleotides listed in [Extended Data Table 2](#T2){ref-type="table"}.

[pTR208]{.ul} was generated by two-fragment PCR. oTR384/oTR385 and oTR386/oTR387 were used to amplify products using pTR74 and *B. subtilis* 168CA genomic DNA as templates, respectively. An equal volume of each PCR product was mixed, heated to 98°C and allowed to cool to room temperature before *Dpn*I digestion and transformation.

[pTR229]{.ul} \[bla ~pT7~(his6-link-Xa-dnaA)\] was generated by subcloning a *Hin*dIII-*Xho*I fragment of *dnaA* from pHM239 into the pTR74 backbone.

[pTR541 and pTR542]{.ul} were generated by two-fragment PCR. oTR537 and oTR538 were used to amplify the plasmid backbone of pSG1301. oTR535 and oTR536 were used to amplify *incC* with *B. subtilis* 168CA genomic DNA and pTR84 used as the templates for pTR541 and pTR542, respectively. An equal volume of each PCR product was mixed, heated to 98°C and allowed to cool to room temperature before *Dpn*I digestion and transformation into EH3827 (*asnB*32 *relA*1 *spoT*1 *thi*-1 *fuc*-1 *lysA ilv*-192 *zia*::pKN500 Δ*dnaA mad*-1)[@R33]. DNA sequencing confirmed the construction of each origin including flanking sequences (\>400 bp upstream and downstream).

Extended Data {#S14}
=============

![Structure of DnaA proteins.\
**(a)** Primary domain structure of DnaA. Key functions are listed below the relevant domain. **(b)** Structure of *Thermatoga maritima* DnaA domain III, highlighting the single-strand binding residue Val176 (Ile190 *B. subtilis*) within the ISM (PDB 2Z4S). **(c)** Structure of *Escherichia coli* DnaA domain IV bound to a DnaA-box (PDB 1J1V). **(d)** Structure of *Aquifex aeolicus* DnaA domain III (blue shades) and domain IV (cyan shades) bound to a single DNA strand (orange), highlighting the single-strand binding residue Val156 (Ile190 *B. subtilis*) (PDB 3R8F). **(e)** Scheme used to construct mutants within the *B. subtilis* DNA replication origin. The green arrow highlights the location of a DnaA-box mutation.](emss-68322-f005){#F5}

![Characterisation of the inducible *repN/oriN* replication initiation system.\
Repression of *repN* expression inhibits DNA replication in a Δ*oriC* mutant. A large deletion was introduced into the *B. subtilis* replication origin using a strain harbouring the inducible *oriN/repN* construct. Strain growth was found to be dependent upon addition of the inducer IPTG. **(a)** Strains streaked to resolve single colonies. **(b)** A GFP-DnaN reporter was used to detect DNA replication following removal of IPTG from inducible *oriN/repN* strains. Scale bar = 5 μm. **(c)** Genetic map indicating the location of *oriN* at the *aprE* locus in strain HM1108. **(d)** Analysis of DNA replication initiation at *oriC* and *oriN*. Marker frequency analysis was used to measure the rate of DNA replication initiation in the presence and absence of IPTG (0.1 mM). Genomic DNA was harvested from cells during the exponential growth phase and the relative amount of DNA from either the endogenous replication origin (*ori*C) or the *aprE* locus (*oriN*) compared to the terminus (*ter*) was determined using qPCR (mean and s.d. of 3 technical replicates). Cell doubling times (min) are shown above each data set.](emss-68322-f006){#F6}

![Wild-type DnaA assembles into filaments on 5′-tailed substrates.\
DnaA filament formation using amine-specific crosslinking (BS^3^) on DNA scaffolds (represented by symbols above each lane). Protein complexes were resolved by SDS-PAGE and DnaA was detected by Western blot analysis.](emss-68322-f007){#F7}

![DNA sequence of unwinding regions following mononucleotide and trinucleotide deletions.\
Resulting sequences grouped in boxes are identical for more than one deletion.](emss-68322-f008){#F8}

![Crosslinking with BS^3^ captures a distinct DnaA oligomer.\
DnaA was incubated with various DNA scaffolds and different crosslinking agents were added to capture distinct DnaA oligomers. **(a)** Crosslinking with BMOE detects DnaA oligomers forming on both duplex and tailed substrates. **(b)** Crosslinking with BS^3^ only detects DnaA oligomers forming on tailed substrates, revealing an interaction between DnaA and the first DnaA-trio motif located downstream of the GC-cluster.](emss-68322-f009){#F9}

![The nucleotide at the third position of the DnaA-trio is required to stabilise DnaA.\
DNA scaffolds containing the first two nucleotides of a DnaA-trio either with or without a 5'-phosphate are unable to stabilise binding of an additional DnaA protomer, indicating that the nucleotide at the third position is required. Combined with the data shown in [Fig. 4b](#F4){ref-type="fig"} where the position is abasic, the results suggest that the sugar at the third position plays a critical role in DnaA binding.](emss-68322-f010){#F10}

![Relationship between the DnaA-box and the DnaA-trios.\
(a) Sequence of the origin region used for constructing DNA scaffolds. Symbols below represent duplex DnaA-boxes (triangles), the GC-rich region (green rectangles), the two strands of the unwinding region (red or pink rectangles), and the AT-rich region (blue rectangle). **(b)** Loading of the DnaA filament onto a single-stranded 5′-tail requires a DnaA-box and DnaA domains III-IV, but the DnaA-box position and orientation are flexible.](emss-68322-f011){#F11}

###### Bacterial replication origin regions in [Figure 4c](#F4){ref-type="fig"}.

  Organism                                Genome accession \#   Reference or Dori C accession \# (ORI)   Genome position shown in [Figure 4](#F4){ref-type="fig"}   Tandem DnaA -boxes (spacing)
  --------------------------------------- --------------------- ---------------------------------------- ---------------------------------------------------------- ------------------------------
  Aquifex aeolicus VF5                    NC_000918             [@R17]                                   166853 to 166897                                           N
  Bacillus subtilis 168                   NC_000964             [@R34]                                   1860 to 1902                                               Y (-1)
  Bdellovibrio bacteriovorus HD100        NC_005363             ORI10040030                              1569 to 1597                                               N
  Bifidobacterium bifidum PRL2010         NC_014638             ORI94010761                              2048 to 2071                                               Y (0)
  Bordetella pertussi s Tohama I          NC_002929             ORI10030012                              4084583 to 4084611                                         Y (+3)
  Borrelia afzelii HLJ01                  NC_018887             ORI96010684                              460118 to 460149                                           Y? (+1)(+9)
  Clostridium botulinum A str. Hall       NC_009698             ORI92010335                              1517 to 1552                                               Y (-1)
  Corynebacterium glutamicum ATCC 13032   NC_003450             ORI10010055                              1984 to 2010                                               Y (0)
  Enterococcus faecalis V583              NC_004668             ORI10010096                              1498 to 1533                                               Y (0)
  Escherichia col i MG1655                NC_000913             [@R35]                                   3925780 to 3925809                                         N
  Helicobacter pylor i 26695              NC_000915             [@R20]                                   1607488 to 1607525                                         Y (0)
  Leuconostoc citreum KM20                NC_010471             ORI92310382                              1790 to 1819                                               Y (0)
  Listeria monocytogenes EGD-e            NC_003210             ORI10010047                              1773 to 1802                                               Y (-1)
  Oceanobacillu s iheyensi s HTE831       NC_004193             ORI10010074                              1746 to 1778                                               Y (-1)
  Staphylococcus aureus NCTC 8325         NC_007795             ORI10010183                              2075 to 2104                                               Y (-1)
  Streptococcus pneumoniae R6             NC_003098             ORI10010044                              1458 to 1487                                               Y (0)
  Streptomyces coelicolor A3(2)           NC_003888             [@R36]                                   4270070 to 4270096                                         Y (0)
  Synechococcus elongatus PCC 7942        NC_007604             [@R37]                                   2695870 to 2695899                                         Y (0)
  Thermotoga maritim a MSB8               NC_000853             [@R21]                                   157010 to 157040                                           N
  Treponema pallidum Nichols              NC_000919             ORI10010003                              1568 to 1588                                               Y (-1)

###### Oligonucleotides used for plasmid construction.

  Product   Template      Primer \#1   Sequence (5〿〿3〿)                                                  Primer \#2   Sequence (5〿〿3〿)
  --------- ------------- ------------ ----------------------------------------------------------------- ------------ ---------------------------------------------------------------
  pHM453    Genomic DNA   oHM319       AATAATGACGTCGGCAAATTGTTTGAATTTGTC                                 oHM320       AATAATAGACGTCAGCCCGACACGCAGTTCATC
  pHM492    Genomic DNA   oHM313       AATAATGAATTCTTAATTATCTAACCAATTATAAAACGGCAC                        oHM315       AATAATCTCGAGCGCTTGGCAGCACCTGAGCAAACC
  pHM560    Genomic DNA   oHM510       AATAATGATATCTATAATGGTACCTATATAAGGCCTAGATTGTGACAACCATTG            oHM511       AATATAAAGCTTAGAGGAAAGGTAGGATTAG
  pTR54     pHM327        oTR36        CTTCTACCATTATCCGTTAGGAGGATAAAAATGAAATTCAC                         oTR37        GGATAATGGTAGAAGTAATAGTAGGGCCTGTGGATTTG
  pTR72     pGS43         oTR156       CAGCTTAAATGAGATCCGGCTGCTAACAAAGCCCGAAAGG                          oTR157       CGGATCTCATTTAAGCTGTTCTTTAATTTCTTTTACATGC
  pTR73     pTR72         oTR158       CATCATCATCATCATCACAGCGAAAATATATTAGACCTGTGGAACCAAGCCCTTGCTCAAATC   oTR159       GCTGTGATGATGATGATGATGCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTC
  pTR74     pTR102        oTR189       ATTCAAGGTCGCATGGAAAATATATTAGACCTGTGGAACCAAGCCCTTG                 oTR190       TTTCCATGCGACCTTGAATGCCGCTGCTGTGATGATGATGATGATGCATG
  pTR83     pHM327        oTR82        CACAGTCTTCCTTGCTGTGGATAGGCTGTGTTTCCTGTCTTTTTC                     oTR83        ATCCACAGCAAGGAAGACTGTGTATGACTTCCGAAAAGTTATTC
  pTR84     pHM328        oTR66        GCCCATGATAATGAAGATGATATTTTTATAAATATATATATTAATACATTATCCGTTAG       oTR67        AAAATATCATCTTCATTATCATGGGCCTGTGGATTTGTGGATAAGTTG
  pTR85     pHM327        oTR118       GAAAGGCAAGGAAGCTTTTCGGAAGTCATACACAGTCTGTC                         oTR119       AAAGCTTCCTTGCCTTTCCCCGATTGATCCCCGGTCCTG
  pTR86     pHM327        oTR123       GAAGCTTCCTTGCGTCTGTCCACATGTGGATAGGCTGTGTTTCC                      oTR124       AGACGCAAGGAAGCTTCCGAAAAGTTATTCACACTTTCCCCGATTG
  pTR87     pHM327        oTR125       ACAGCAAGGAAGGCTGTGTTTCCTGTCTTTTTCACAACTTATC                       oTR126       CAGCCTTCCTTGCTGTGGACAGACTGTGTATGACTTCCGAAAAG
  pTR88     pHM327        oTR86        CCTGTCCTTCCTTGCACTTATCCACAAATCCACAGGCCCTACTATTAC                  oTR87        GGATAAGTGCAAGGAAGGACAGGAAACACAGCCTATCCAC
  pTR89     pHM327        oTR88        TCACAACCTTCCTTGCAATCCACAGGCCCTACTATTACTTCTAC                      oTR89        GTGGATTGCAAGGAAGGTTGTGAAAAAGACAGGAAACACAGCCTATC
  pTR90     pHM327        oTR090       CCACATTCCTTGCGGCCCTACTATTACTTCTAC                                 oTR091       GGGCCGCAAGGAATGTGGATAAGTTGTGAAAAAGACAGGAAAC
  pTR102    pTR73         oTR187       CAGCAGCGGCATTCGAAAATATATTAGACCTGTGGAACCAAGCCCTTG                  oTR188       TTTCGAATGCCGCTGCTGTGATGATGATGATGATGCATGGTATATC
  pTR127    pHM327        oTR219       TTTGTGGATAAGGCCCTACTATTACTTCTAC                                   oTR220       CCTTATCCACAAATCCACAGTTGTGAAAAAGAC
  pTR146    pHM327        oTR247       CAGGCCCATGTATTACTTCTACTATTTTTTATAAATATATATATTAATAC                oTR248       AATACATGGGCCTGTGGATTTGTGGATAAGTTGTG
  pTR147    pHM327        oTR249       GCCCTACATATACTTCTACTATTTTTTATAAATATATATATTAATACATTATC             oTR250       AGTATATGTAGGGCCTGTGGATTTGTGGATAAGTTGTG
  pTR148    pHM327        oTR251       CCCTACTATATGTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG        oTR252       GAACATATAGTAGGGCCTGTGGATTTGTGGATAAGTTGTG
  pTR149    pHM327        oTR254       AGTACTTGTAATAGTAGGGCCTGTGGATTTGTGGATAAG                           oTR263       CTACTATTACAAGTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAGGAG
  pTR150    pHM327        oTR255       TACTTCATGTATTTTTTATAAATATATATATTAATACATTATCCGTTAGGAG              oTR256       AATACATGAAGTAATAGTAGGGCCTGTGGATTTGTG
  pTR153    pHM327        oTR261       GATCAATCGGTATCCGTTAGGAGGATAAAAATGAAATTC                           oTR262       CTAACGGATACCGATTGATCCCCGGTCCTGCTATTTAAG
  pTR168    pTR74         oTR299       GAATTCGCCTGCTCTATCCGAGATAATAAATGC                                 oTR300       GAGCAGGCGAATTCGTTTGTAAATTTCTCAGAAG
  pTR189    pHM327        oTR217       CAACTGTGGATAAAATCCACAGGCCCTACTATTACTTCTAC                         oTR218       GATTTTATCCACAGTTGTGAAAAAGACAGGAAACACAG
  pTR208    pTR74         oTR384       TCAAGGTCGCATGAACAAAACAGAACTTATCAATG                               oTR385       CGGATCTTATTTTCCGGCAACTGCGTCTTTAAGC
  pTR208    Genomic DNA   oTR386       TTTTGTTCATGCGACCTTGAATGCCGCTGCTG                                  oTR387       CGGAAAATAAGATCCGGCTGCTAACAAAGCCCGAAAG
  pTR284    pHM327        oTR449       GGCCCAACTATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC            oTR450       GTAATAGTTGGGCCTGTGGATTTGTGGATAAG
  pTR285    pHM327        oTR451       GGCCCTTCTATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC            oTR452       GTAATAGAAGGGCCTGTGGATTTGTGGATAAG
  pTR286    pHM327        oTR453       GGCCCTAGTATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATCCG          oTR454       GTAATACTAGGGCCTGTGGATTTGTGGATAAG
  pTR287    pHM327        oTR455       CCCTACAATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG        oTR456       AGTAATTGTAGGGCCTGTGGATTTGTGG
  pTR288    pHM327        oTR457       CCCTACTTTTACTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG        oTR458       GAAGTAAAAGTAGGGCCTGTGGATTTGTGGATAAG
  pTR289    pHM327        oTR459       CCCTACTAATACTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG        oTR460       GTATTAGTAGGGCCTGTGGATTTGTGGATAAG
  pTR301    pHM327        oTR469       CTTCTACTTTTTATAAATATATATATTAATACATTATCCGTTAGGAGGATAAAAATG         oTR470       TATAAAAAGTAGAAGTAATAGTAGGGCCTGTGG
  pTR302    pHM327        oTR471       TTACTTCTTTTTATAAATATATATATTAATACATTATCCGTTAGGAGGATAAAAATG         oTR472       TATAAAAAGAAGTAATAGTAGGGCCTGTGGATTTG
  pTR303    pHM327        oTR473       CTATTACTTTTTATAAATATATATATTAATACATTATCCGTTAGGAGGATAAAAATG         oTR474       TATAAAAAGTAATAGTAGGGCCTGTGGATTTG
  pTR304    pHM327        oTR475       CAGGCCCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAGGAG             oTR476       AATAGTAGGGCCTGTGGATTTGTGGATAAG
  pTR305    pHM327        oTR477       GCCCTACTTTTTATAAATATATATATTAATACATTATCCGTTAGGAGGATAAAAATG         oTR478       TTATAAAAAGTAGGGCCTGTGGATTTGTG
  pTR306    pHM327        oTR479       GGCCCTTTTTATAAATATATATATTAATACATTATCCGTTAGGAGGATAAAAATG           oTR480       TATAAAAAGGGCCTGTGGATTTGTGG
  pTR346    pHM327        oTR490       GGCCCACTATTACTTCTACTATTTTTTATAAATATATATATTAATAC                   oTR491       GAAGTAATAGTGGGCCTGTGGATTTGTGGATAAGTTG
  pTR348    pHM327        oTR494       GGCCCTATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC               oTR495       AGAAGTAATAGGGCCTGTGGATTTGTGGATAAGTTG
  pTR349    pTR54         oTR496       ATTACTTCCATTATCCGTTAGGAGGATAAAAATGAAATTC                          oTR497       GATAATGGAAGTAATAGTAGGGCCTGTGGATTTG
  pTR350    pTR54         oTR498       ACTATTACCATTATCCGTTAGGAGGATAAAAATG                                oTR499       GGATAATGGTAATAGTAGGGCCTGTGGATTTGTG
  pTR377    pHM327        oTR539       GGCCCTATATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC             oTR540       GTAATATAGGGCCTGTGGATTTGTG
  pTR441    pHM327        oTR659       CCCTACATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC               oTR660       GTAGAAGTAATGTAGGGCCTGTGGATTTGTG
  pTR443    pHM327        oTR663       CCCTACTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC                 oTR664       GTAGAAGTAGTAGGGCCTGTGGATTTGTG
  pTR452    pHM326        oTR698       GGCCGTACTATTACTTCTACTATTTTTTATAAATATATATATTAATAC                  oTR699       GTAATAGTACGGCCTGTGGATTTGTGG
  pTR453    pHM327        oTR700       AGGCCTACTATTACTTCTACTATTTTTTATAAATATATATATTAATAC                  oTR701       GTAATAGTAGGCCTGTGGATTTGTGG
  pTR456    pHM327        oTR706       GCCCTCTATTACTTCTACTATTTTTTATAAATATATATATTAATACATTATC              oTR707       AAGTAATAGAGGGCCTGTGGATTTGTG
  pTR457    pHM327        oTR708       CCCTACTTTACTTCTACTATTTTTTATAAATATATATATTAATACATTATCC              oTR709       GAAGTAAAGTAGGGCCTGTGGATTTG
  pTR458    pHM327        oTR710       CCTACTATACTTCTACTATTTTTTATAAATATATATATTAATACATTATCC               oTR711       TAGAAGTATAGTAGGGCCTGTGGATTTG
  pTR475    pHM327        oTR795       CTACTATAACTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG          oTR796       TAGAAGTTATAGTAGGGCCTGTGGATTTGTG
  pTR476    pHM327        oTR797       TACTATTTCTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG           oTR798       GTAGAAGAAATAGTAGGGCCTGTGGATTTGTG
  pTR477    pHM327        oTR799       ACTATTAGTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG            oTR800       AGTAGAACTAATAGTAGGGCCTGTGGATTTGTG
  pTR478    pHM327        oTR801       TACTATTCTTCTACTATTTTTTATAAATATATATATTAATACATTATCCGTTAG            oTR802       GTAGAAGAATAGTAGGGCCTGTGGATTTGTG
  pTR541    Genomic DNA   oTR535       ATTACGCCAGCTAGTGCTTTTATTTCTTGCAACCATAATAG                         oTR536       ATTAATGCAGTTTTATCCTCCTAACGGATAATG
  pTR541    pSG1301       oTR537       AAAGCACTAGCTGGCGTAATAGCGAAGAGG                                    oTR538       GAGGATAAAACTGCATTAATGAATCGGCCAACG
  pTR542    pTR84         oTR535       ATTACGCCAGCTAGTGCTTTTATTTCTTGCAACCATAATAG                         oTR536       ATTAATGCAGTTTTATCCTCCTAACGGATAATG
  pTR542    pSG1301       oTR537       AAAGCACTAGCTGGCGTAATAGCGAAGAGG                                    oTR538       GAGGATAAAACTGCATTAATGAATCGGCCAACG

###### Oligonucleotides used to assemble DNA scaffolds.

  Oligo 1   Sequence (5〿〿3〿)                                              O ligo 2   Sequence (5〿〿3〿)                                              Figure
  --------- ------------------------------------------------------------- ---------- ------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR603     GGGCCTGTGGATTTGTGGATAAGT                                      [2c](#F2){ref-type="fig"}, [2f](#F2){ref-type="fig"}, [4a](#F4){ref-type="fig"}, [E5a](#F9){ref-type="fig"}, [E5b](#F9){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR609     ATATATATTTATAAAAAATAGTAGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT   [2c](#F2){ref-type="fig"}, [E3](#F7){ref-type="fig"}, [E7b](#F11){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR619     ATATATATTTATAAAAATATCATCTTCATTATCATGGGCCTGTGGATTTGTGGATAAGT   [2c](#F2){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR626     AGGGCCTGTGGATTTGTGGATAAGT                                     [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR627     TAGGGCCTGTGGATTTGTGGATAAGT                                    [4a](#F4){ref-type="fig"}, [E5a](#F9){ref-type="fig"}, [E5b](#F9){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR628     GTAGGGCCTGTGGATTTGTGGATAAGT                                   [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR629     AGTAGGGCCTGTGGATTTGTGGATAAGT                                  [4a](#F4){ref-type="fig"}, [E6](#F10){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR630     TAGTAGGGCCTGTGGATTTGTGGATAAGT                                 [4a](#F4){ref-type="fig"}, [4b](#F4){ref-type="fig"}, [E5a](#F9){ref-type="fig"}, [E5b](#F9){ref-type="fig"}, [E6](#F10){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR631     ATAGTAGGGCCTGTGGATTTGTGGATAAGT                                [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR632     AATAGTAGGGCCTGTGGATTTGTGGATAAGT                               [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR633     TAATAGTAGGGCCTGTGGATTTGTGGATAAGT                              [4a](#F4){ref-type="fig"}, [2f](#F2){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR634     GTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                             [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR645     AGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                            [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR646     AAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                           [4a](#F4){ref-type="fig"}, [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR647     GAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                          [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR648     AGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                         [4a](#F4){ref-type="fig"}, [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR649     TAGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                        [4a](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR754     TATAAAAAATAGTAGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT            [2f](#F2){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR831     TAGTAGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT                     [2f](#F2){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR854     TAGTAGTAGTAGTAGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT            [2f](#F2){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR956     AAGAAGTAATATAGGGCCTGTGGATTTGTGGATAAGT                         [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR957     AAGAAGTAATGTAGGGCCTGTGGATTTGTGGATAAGT                         [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR958     AAGAAGTAAAGTAGGGCCTGTGGATTTGTGGATAAGT                         [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR959     AAGAAGTATAGTAGGGCCTGTGGATTTGTGGATAAGT                         [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR960     AAGAAGAATAGTAGGGCCTGTGGATTTGTGGATAAGT                         [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR961     AAGAAGTAATAGGGCCTGTGGATTTGTGGATAAGT                           [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR962     AAGAAGTAGTAGGGCCTGTGGATTTGTGGATAAGT                           [3d](#F3){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR965     pAGTAGGGCCTGTGGATTTGTGGATAAGT                                 [E6](#F10){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR970     \"AGTAGGGCCTGTGGATTTGTGGATAAGT                                [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR971     T^n^GTAGGGCCTGTGGATTTGTGGATAAGT                               [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR972     TA^n^TAGGGCCTGTGGATTTGTGGATAAGT                               [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR995     TAATAGGGCCTGTGGATTTGTGGATAAGT                                 [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR996     TACTAGGGCCTGTGGATTTGTGGATAAGT                                 [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR998     TGGTAGGGCCTGTGGATTTGTGGATAAGT                                 [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR999     TTGTAGGGCCTGTGGATTTGTGGATAAGT                                 [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR1001    CAGTAGGGCCTGTGGATTTGTGGATAAGT                                 [4b](#F4){ref-type="fig"}
  oTR602    ACTTATCCACAAATCCACAGGCCC                                      oTR1002    AAGTAGGGCCTGTGGATTTGTGGATAAGT                                 [4b](#F4){ref-type="fig"}
  oTR603    GGGCCTGTGGATTTGTGGATAAGT                                      oTR608     ACTTATCCACAAATCCACAGGCCCTACTATTACTTCTACTATTTTTTATAAATATATAT   [2c](#F2){ref-type="fig"}, [E3](#F7){ref-type="fig"}
  oTR608    ACTTATCCACAAATCCACAGGCCCTACTATTACTTCTACTATTTTTTATAAATATATAT   oTR609     ATATATATTTATAAAAAATAGTAGAAGTAATAGTAGGGCCTGTGGATTTGTGGATAAGT   [2c](#F2){ref-type="fig"}
  oTR611    ACCTTCCTTGCTTCCTTGCGGCCC                                      oTR612     ATATATATTTATAAAAAATAGTAGAAGTAATAGTAGGGCCGCAAGGAAGCAAGGAAGGT   [2c](#F2){ref-type="fig"}, [E7b](#F11){ref-type="fig"}
  oTR665    ATATATATTTATAAAAAATAGTAGAAGTAATAGTAGGGCCTGTGGATTGCAAGGAAGGT   oTR667     ACCTTCCTTGCAATCCACAGGCCC                                      [E7b](#F11){ref-type="fig"}
  oTR666    ATATATATTTATAAAAAATAGTAGAAGTAATAGTAGGGCCGCAAGGAATGTGGATAAGT   oTR668     ACTTATCCACATTCCTTGCGGCCC                                      [E7b](#F11){ref-type="fig"}
  oTR946    ACTGTGGATTTGTGGATAAGGCCC                                      oTR623     ATATATATTTATAAAAAATAGTAGAAGTAATAGTAGGGCCTTATCCACAAATCCACAGT   [E7b](#F11){ref-type="fig"}
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![Genetic analysis of the *oriC* DNA unwinding element reveals a critical region required for initiation activity.\
**(a)** *B. subtilis oriC* unwinding region. DnaA-box colouring indicates conservation (consensus 5′-TTATCCACA-3′ in black). **(b)** The *oriC-*independent strain used for constructing replication origin mutations. **(c)** Growth of an *oriC* deletion mutant is dependent upon *oriN* activity. **(d)** Deletions extending beyond the AT-cluster into the initially unwound region inhibit cell growth. **(e)** Sequences between the GC-rich and AT-rich clusters are essential for origin function. **(f)** Sequences proximal to DnaA-boxes are most important for origin function. Marker frequency analysis was used to measure the rate of DNA replication initiation (mean and s.d. of 3 technical replicates). **(g)** Open complex formation by DnaA requires the native sequence between the GC- and AT-clusters. DNA duplex unwinding was probed by KMnO~4~ and detected by primer extension.](emss-68322-f001){#F1}

![DnaA filaments are loaded from DnaA-boxes onto a specific single-strand sequence within the initially unwound region.\
**(a)** DnaA-boxes proximal to the unwinding region are most important for origin function. Marker frequency analysis was used to measure the rate of DNA replication initiation (mean and s.d. of 3 technical replicates). **(b)** Sequence of the origin region used for constructing DNA scaffolds in (c). **(c)** DnaA filament formation using cysteine-specific crosslinking on DNA scaffolds. DnaA complexes were resolved by SDS-PAGE and detected by Western blot analysis. **(d)** Crystal structure showing ssDNA (dA~12~) bound to the DnaA filament through the AAA+ domain (PDB: 3R8F). **(e)** Sequence of the origin region used for constructing DNA scaffolds in (f). **(f)** DnaA filament formation on tailed substrates is arrested by a poly(A) tract. Long oligomers highlighted within the dotted box are shown above with increased contrast.](emss-68322-f002){#F2}

![Analysis of the key origin unwinding region provides evidence for functional 3-mer repeats.\
**(a)** Mutagenesis identifies A:T base pairs spaced three nucleotides apart are most critical for origin activity. Marker frequency analysis was used to measure the rate of DNA replication initiation (mean and s.d. of 3 technical replicates). **(b)** Crystal structure showing the interaction of DnaA with sets of three nucleotides (PDB: 3R8F). Residues for *A. aeolicus* indicated above; *B. subtilis* below. **(c)** *In vivo* deletion analysis of the unwinding region. Isogenic deletions indicated in black. Marker frequency analysis was used to measure the rate of DNA replication initiation (mean and s.d. of 3 technical replicates). **(d)** Growth of mutants used in (**c**). **(e)** *In vitro* deletion analysis of tailed substrates.](emss-68322-f003){#F3}

![Identification of the DnaA-trio motif.\
**(a)** Varying the length of 5′-tailed substrates identifies the likely DnaA-trio sequence. Lane 2 shows DnaA filament formation on a duplex DNA scaffold (DnaA-box6, DnaA-box7, GC-rich cluster). Letters indicate the nucleotide sequentially added to the 5′-tail. **(b)** Targeted mutagenesis of the proposed DnaA-trio motif. **(c)** Bioinformatic analysis identifies DnaA-trio motifs adjacent to a DnaA-box throughout the bacterial kingdom. Underlined sequences indicate experimentally determined DnaA-dependent unwinding sites. **(d)** DnaA-trios sequence logo (WebLogo[@R28]). **(e)** A schematic of DnaA filament formation from double-stranded DnaA-boxes (triangles) onto a single strand containing the DnaA-trios.](emss-68322-f004){#F4}
